Millipore in $1.6B makeover as life sciences supplier

Millipore is expanding on its reputation as a filtration supplier to scientific labs around the globe. Known for purified water and filters, Millipore has leveraged several buyouts to increase its offerings to a range of investigative tools for drug research. The company supplies a range of biopharma research operations, including investigators at Pfizer, Biogen Idec and Genzyme, according to a recent profile in the Boston Globe. In a bid to radically transform itself, Millipore went on a buying spree, acquiring Serologicals, Newport Bio Systems, NovAseptic and MicroSafe for more than $1.6 billion. And it's launched a marketing campaign to get the word out.

- see Millipore's release
- here's the article from The Boston Globe

Related Article:
Millipore to pay $1.4B for Serologicals. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.